IXELLES PHARMA
The computed 12-month bankruptcy probability of IXELLES PHARMA is 1.1% (low). The company has been active since 2002 and the Belgian State Gazette contains no insolvency or warning signals. No processed annual-account figures are available; this conclusion rests on registry and State Gazette data only.
| Active | 23 yrs |
| Locations | 1 |
| Publications | 1 |
Statistical estimate based on public sources, not credit advice nor a finding of fact. How do we compute this?
| Fiscal year | Type | Filed | Reference |
|---|---|---|---|
| 31-12-2025 | volledig | 27-04-2026 | 2026-00089092 |
| 31-12-2024 | volledig | 01-07-2025 | 2025-00217974 |
| 31-12-2023 | volledig | 02-07-2024 | 2024-00207776 |
| 31-12-2022 | volledig | 28-06-2023 | 2023-00181929 |
| 31-12-2021 | volledig | 30-05-2022 | 2022-20040669 |
| 31-12-2020 | volledig | 07-06-2021 | 2021-17900505 |
| 31-12-2019 | volledig | 05-06-2020 | 2020-15100075 |
| 31-12-2018 | volledig | 27-08-2019 | 2019-53900362 |
| 31-12-2017 | volledig | 07-08-2018 | 2018-44100120 |
| 31-12-2016 | volledig | 28-08-2017 | 2017-49900419 |
| NACE primary | Detailhandel in farmaceutische producten(47730) |
| Legal form | Private limited company(610) |
| Incorporation | 09-09-2002 |
| Status | Active |
| Postal code | 1050 |
Parcels linked to this company through its CBE addresses (seat, establishment units, branches), cross-referenced with the cadastral parcel plan. This shows where the company operates, not a deeds register.
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 21443A0230/00X000 | Brussels | 302 m² | 1 · 263 m² | 31.8 m · 10 fl. |
A single timeline of everything that happened to this company, publications, insolvency and lifecycle events, administrative changes and filed annual accounts.
22-05-2025 Publication in the Belgian Official Gazette, Miscellaneous
Technical details
{
"stage": null,
"notary": {
"name": "Thi Thuy Mai HONG",
"firm_city": null,
"firm_name": "Pierre STERCKMANS \u0026 Thi Thuy Mai HONG, Notaires associ\u00E9s",
"office_city": "Tubize",
"is_associated": true
},
"act_meta": {
"language": "mixed",
"pub_date": "2025-05-22",
"filing_date": "2025-05-20",
"act_kind_objet": "MODIFICATION FORME JURIDIQUE, STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS), DIVERS"
},
"decision": {
"body": "algemene_vergadering",
"act_date": "2025-05-06",
"unanimous": null
},
"conversion": null,
"detected_kind": "other",
"report_waiver": null,
"restructuring": null,
"subject_company": {
"kbo": "0478.282.551",
"name_full": "IXELLES PHARMA",
"legal_form": "SRL"
},
"detected_kind_raw": "material_correction",
"publication_proxy": {
"kind": "org",
"org_kbo": null,
"org_name": null,
"person_name": null,
"org_rep_person_name": null
},
"summary_narrative": "L\u0027assembl\u00E9e g\u00E9n\u00E9rale extraordinaire de la soci\u00E9t\u00E9 \u00E0 responsabilit\u00E9 limit\u00E9e \u00AB IXELLES PHARMA \u00BB a d\u00E9cid\u00E9 de modifier ses statuts pour les adapter au Code des soci\u00E9t\u00E9s et des associations. Cette modification inclut la conversion du capital lib\u00E9r\u00E9 en capitaux propres indisponibles, la suppression de ce compte, et l\u0027adoption de nouveaux statuts. L\u0027assembl\u00E9e a \u00E9galement d\u00E9cid\u00E9 de mettre fin \u00E0 la fonction de l\u0027administrateur actuel et de le renouveler, de fixer le si\u00E8ge social \u00E0 Ixelles, et de d\u00E9signer un mandataire ad hoc pour les formalit\u00E9s administratives.",
"co_filed_documents": [
"les statuts coordonn\u00E9s"
],
"detected_real_type": "other",
"referenced_correction": null,
"should_reroute_to_category": null
}Generate a structured, factual brief from every signal in this dossier: risk, financial health, ownership, mandates and sector comparison.
| Legal nameFR | IXELLES PHARMA |